Author(s): Smith EE; Phillips NA; Feldman HH; Borrie M; Ganesh A; Henri-Bhargava A; Desmarais P; Frank A; Badhwar A; Barlow L; Bartha R; Best S; Bethell J; Bhangu J; Black SE; Bocti C; Bronskill SE; Burhan AM; Calon F; Camicioli R; Campbell B; Coll ...

Lecanemab and donanemab are monoclonal antibody therapies that remove amyloid-beta from the brain. They are the first therapies that alter a fundamental mechanism, amyloid-beta deposition, in Alzheimer disease (AD). To inform Canadian decisions on approval and use of these drugs, the Canadian Con ...

Article GUID: 39893139

Author(s): Chen Q; Allot A; Leaman R; Islamaj R; Du J; Fang L; Wang K; Xu S; Zhang Y; Bagherzadeh P; Bergler S; Bhatnagar A; Bhavsar N; Chang YC; Lin SJ; Tang W; Zhang H; Tavchioski I; Pollak S; Tian S; Zhang J; Otmakhova Y; Yepes AJ; Dong H; Wu H; ...

The coronavirus disease 2019 (COVID-19) pandemic has been severely impacting global society since December 2019. The related findings such as vaccine and drug development have been reported in biomedical literature-at a rate of about 10 000 articles on COVID-19 per month. Such rapid growth signif ...

Article GUID: 36043400